Asymptomatic HIV-infected Individuals on Antiretroviral Therapy Exhibit Impaired Lung CD4(+) T-cell Responses to Mycobacteria

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2014 Sep 17

PMID 25225948

Citations 24

Authors

Kondwani C Jambo

Dominic H Banda

Louise Afran

Anstead M Kankwatira

Rose D Malamba

Theresa J Allain

Stephen B Gordon

Robert S Heyderman

David G Russell

Henry C Mwandumba

Affiliations

Soon will be listed here.

Abstract

Rationale: HIV-infected persons on antiretroviral therapy (ART) remain at higher risk of pulmonary tuberculosis (TB) than HIV-uninfected individuals. This increased susceptibility may be caused by impairment of alveolar macrophage (AM) function and/or mycobacteria-specific alveolar CD4(+) T-cell responses observed in HIV-infected ART-naive adults.

Objectives: To determine whether ART was associated with improvement in both AM function, assessed by phagosomal proteolysis, and alveolar CD4(+) T-cell responses to Mycobacterium in HIV-infected individuals.

Methods: Peripheral blood was drawn and bronchoalveolar lavage (BAL) performed on healthy, 35 HIV-uninfected, 25 HIV-infected ART-naive, and 50 HIV-infected ART-treated asymptomatic adults. Phagosomal proteolysis of AM was assessed with fluorogenic beads. Mycobacteria-specific CD4(+) T-cell responses were measured by intracellular cytokine staining.

Measurements And Main Results: HIV-infected adults on ART exhibited lower plasma HIV viral load and higher blood CD4(+) T-cell count than ART-naive adults. AM proteolysis and total mycobacteria-specific Th1 CD4(+) T-cell responses in individuals on ART for greater than or equal to 4 years were similar to HIV-uninfected control subjects but those on ART for less than 4 years had impaired responses. Total influenza-specific alveolar Th1 CD4(+) T-cell responses were intact in all individuals receiving ART. In contrast, BAL and blood mycobacteria-specific polyfunctional CD4(+) T-cell responses were impaired in adults on ART irrespective of duration.

Conclusions: AM and mycobacteria-specific alveolar CD4(+) T-cell responses in HIV-infected adults on ART for less than 4 years are impaired and may partly explain the high risk of TB in HIV-infected individuals on ART. Strategies to augment ART to improve lung immune cell function and reduce the high incidence of TB in HIV-infected adults who initiate ART should be investigated.

Citing Articles

Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection.

Kgoadi K, Bajpai P, Ibegbu C, Dkhar H, Enriquez A, Dawa S Nat Commun. 2025; 16(1):2397.

PMID: 40064940 PMC: 11894076. DOI: 10.1038/s41467-025-57668-y.

Dysfunctional bronchoalveolar effector memory CD8 T cells in tuberculosis-exposed people living with antiretroviral-naïve HIV infection.

Mthembu M, Claassen H, Khuzwayo S, Voillet V, Naidoo A, Spillner J iScience. 2024; 27(11):111137.

PMID: 39563891 PMC: 11575450. DOI: 10.1016/j.isci.2024.111137.

Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection.

Xiao G, Huang W, Zhong Y, Ou M, Ye T, Wang Z J Infect Dis. 2024; 230(3):e524-e535.

PMID: 38412342 PMC: 11420811. DOI: 10.1093/infdis/jiae042.

Macrophages: Key Cellular Players in HIV Infection and Pathogenesis.

Woottum M, Yan S, Sayettat S, Grinberg S, Cathelin D, Bekaddour N Viruses. 2024; 16(2).

PMID: 38400063 PMC: 10893316. DOI: 10.3390/v16020288.

Systems biology approaches to investigate the role of granulomas in TB-HIV coinfection.

Hoerter A, Arnett E, Schlesinger L, Pienaar E Front Immunol. 2022; 13:1014515.

PMID: 36405707 PMC: 9670175. DOI: 10.3389/fimmu.2022.1014515.

References

Wilkinson T, Li C, Chui C, Huang A, Perkins M, Liebner J . Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012; 18(2):274-80. DOI: 10.1038/nm.2612. View

Holt P . Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J. 1993; 6(1):120-9. View

Moore R, Keruly J . CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007; 44(3):441-6. DOI: 10.1086/510746. View

Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P . HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr. 2007; 46(1):72-7. DOI: 10.1097/QAI.0b013e318134257a. View

Baumgarth N, Kelso A . In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol. 1996; 70(7):4411-8. PMC: 190374. DOI: 10.1128/JVI.70.7.4411-4418.1996. View

Gordon S, Read R . Macrophage defences against respiratory tract infections. Br Med Bull. 2002; 61:45-61. DOI: 10.1093/bmb/61.1.45. View

Kalsdorf B, Scriba T, Wood K, Day C, Dheda K, Dawson R . HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med. 2009; 180(12):1262-70. PMC: 2796736. DOI: 10.1164/rccm.200907-1011OC. View

Fullerton D, Suseno A, Semple S, Kalambo F, Malamba R, White S . Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis. 2011; 15(3):391-8. View

Darrah P, Patel D, De Luca P, Lindsay R, Davey D, Flynn B . Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007; 13(7):843-50. DOI: 10.1038/nm1592. View

10.

Suthar A, Lawn S, Del Amo J, Getahun H, Dye C, Sculier D . Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012; 9(7):e1001270. PMC: 3404110. DOI: 10.1371/journal.pmed.1001270. View

11.

Kugathasan K, Roediger E, Small C, McCormick S, Yang P, Xing Z . CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells. BMC Immunol. 2008; 9:48. PMC: 2527294. DOI: 10.1186/1471-2172-9-48. View

12.

Sonnenberg P, Glynn J, Fielding K, Murray J, Godfrey-Faussett P, Shearer S . How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2004; 191(2):150-8. DOI: 10.1086/426827. View

13.

Allie N, Grivennikov S, Keeton R, Hsu N, Bourigault M, Court N . Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci Rep. 2013; 3:1809. PMC: 3648802. DOI: 10.1038/srep01809. View

14.

Houben R, Crampin A, Ndhlovu R, Sonnenberg P, Godfrey-Faussett P, HAAS W . Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis. 2011; 15(1):24-31. View

15.

Wozniak T, Saunders B, Ryan A, Britton W . Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun. 2010; 78(10):4187-94. PMC: 2950338. DOI: 10.1128/IAI.01392-09. View

16.

Forbes E, Sander C, Ronan E, McShane H, Hill A, Beverley P . Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol. 2008; 181(7):4955-64. PMC: 2867031. DOI: 10.4049/jimmunol.181.7.4955. View

17.

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

18.

Chen X, Zhang M, Liao M, Graner M, Wu C, Yang Q . Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med. 2009; 181(7):734-42. DOI: 10.1164/rccm.200909-1463OC. View

19.

Perreau M, Rozot V, Welles H, Belluti-Enders F, Vigano S, Maillard M . Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease. Eur J Immunol. 2013; 43(4):939-48. DOI: 10.1002/eji.201243090. View

20.

Kannanganat S, Kapogiannis B, Ibegbu C, Chennareddi L, Goepfert P, Robinson H . Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol. 2007; 81(21):12071-6. PMC: 2168799. DOI: 10.1128/JVI.01261-07. View